نتایج جستجو برای: ژن brca2

تعداد نتایج: 19908  

Journal: :Molecular cancer research : MCR 2009
Fan Zhang Qiang Fan Keqin Ren Paul R Andreassen

BRCA1 and BRCA2 are prominently associated with inherited breast and ovarian cancer. The encoded proteins function in DNA damage responses, but no functional link between BRCA1 and BRCA2 has been established. We show here that PALB2 physically and functionally connects BRCA1 and BRCA2 into a DNA damage response network that also includes the RAD51 recombinase. PALB2 directly binds BRCA1, as det...

Journal: :Cancer research 2004
Alison M Y Cheung Andrew Elia Ming-Sound Tsao Susan Done Kay-Uwe Wagner Lothar Hennighausen Razqallah Hakem Tak W Mak

Brca2 is an important tumor suppressor associated with susceptibility to breast cancer. Although increasing evidence indicates that the primary function of Brca2 is to facilitate the repair of DNA damage via the homologous recombination pathway, how Brca2 prevents breast cancer is largely unknown. To study the role of Brca2 specifically in mammary epithelium development, we crossed mice bearing...

Journal: :Nucleic Acids Research 2006
Mahmud K. K. Shivji Owen R. Davies Jane M. Savill Debbie L. Bates Luca Pellegrini Ashok R. Venkitaraman

Human BRCA2, a breast and ovarian cancer suppressor, binds to the DNA recombinase RAD51 through eight conserved BRC repeats, motifs of approximately 30 residues, dispersed across a large region of the protein. BRCA2 is essential for homologous recombination in vivo, but isolated BRC repeat peptides can prevent the assembly of RAD51 into active nucleoprotein filaments in vitro, suggesting a mode...

Journal: :Cancer research 1996
K A Foster P Harrington J Kerr P Russell R A DiCioccio I V Scott I Jacobs G Chenevix-Trench B A Ponder S A Gayther

The breast and ovarian cancer susceptibility gene BRCA2 has recently been isolated. A role for BRCA2 in sporadic breast and ovarian cancer has been suggested by loss of heterozygosity (LOH) studies which show frequent LOH in the BRCA2 region at chromosome 13q12. In addition, the observation of nonrandom loss of the wild-type chromosome in a breast/ovarian cancer family which shows linkage to BR...

Journal: :Human molecular genetics 2008
Xiaowei Chen Joellen Weaver Betsy A Bove Lisa A Vanderveer Susan C Weil Alexander Miron Mary B Daly Andrew K Godwin

The contribution of BRCA1 and BRCA2 to familial and non-familial forms of breast cancer has been difficult to accurately estimate because of the myriad of potential genetic and epigenetic mechanisms that can ultimately influence their expression and involvement in cellular activities. As one of these potential mechanisms, we investigated whether allelic imbalance (AI) of BRCA1 or BRCA2 expressi...

Journal: :Cancer research 2011
Hui-Feng Wang Katsuya Takenaka Akira Nakanishi Yoshio Miki

BRCA2 germline mutations account for the majority of heredity breast and ovarian cancer. Besides its role in DNA damage repair, BRCA2 also plays an important role in cytokinesis, transcription regulation, and cancer cell proliferation. Recently, we reported that BRCA2 localizes to centrosomes as well as nuclei and the dysfunction of BRCA2 in a centrosome causes abnormalities in cell division. H...

Journal: :Cancer research 1996
J P Vaughn F D Cirisano G Huper A Berchuck P A Futreal J R Marks J D Iglehart

Identifying the conditions and kinetics of the induction of BRCA2 gene expression may implicate roles for the function of the tumor suppressor gene. In this study, expression of BRCA2 mRNA is shown to be regulated by the cell cycle and associated with proliferation in normal and tumor-derived breast epithelial cells. Cells arrested in G(0) or early G1 contained low levels of BRCA2 mRNA. After r...

2017
Renea A Taylor Michael Fraser Julie Livingstone Shadrielle Melijah G Espiritu Heather Thorne Vincent Huang Winnie Lo Yu-Jia Shiah Takafumi N Yamaguchi Ania Sliwinski Sheri Horsburgh Alice Meng Lawrence E Heisler Nancy Yu Fouad Yousif Melissa Papargiris Mitchell G Lawrence Lee Timms Declan G Murphy Mark Frydenberg Julia F Hopkins Damien Bolton David Clouston John D McPherson Theodorus van der Kwast Paul C Boutros Gail P Risbridger Robert G Bristow

Germline mutations in the BRCA2 tumour suppressor are associated with both an increased lifetime risk of developing prostate cancer (PCa) and increased risk of aggressive disease. To understand this aggression, here we profile the genomes and methylomes of localized PCa from 14 carriers of deleterious germline BRCA2 mutations (BRCA2-mutant PCa). We show that BRCA2-mutant PCa harbour increased g...

Journal: :Cancer research 2000
C S Sinclair R Berry D Schaid S N Thibodeau F J Couch

Epidemiological studies have suggested that the breast cancer susceptibility genes, BRCA1 and BRCA2, may be involved in the development of prostate cancer. Several studies have screened prostate cancer populations for the presence of BRCA1 and BRCA2 mutations, with few mutations identified. In this study, 22 high-risk prostate cancer families (at least three cases of prostate cancer) were scree...

Journal: :Science 2002
Haijuan Yang Philip D Jeffrey Julie Miller Elspeth Kinnucan Yutong Sun Nicolas H Thoma Ning Zheng Phang-Lang Chen Wen-Hwa Lee Nikola P Pavletich

Mutations in the BRCA2 (breast cancer susceptibility gene 2) tumor suppressor lead to chromosomal instability due to defects in the repair of double-strand DNA breaks (DSBs) by homologous recombination, but BRCA2's role in this process has been unclear. Here, we present the 3.1 angstrom crystal structure of a approximately 90-kilodalton BRCA2 domain bound to DSS1, which reveals three oligonucle...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید